Skip to main content
Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
25.49
+1.09 (4.47%)
Feb 21, 2025, 3:00 PM EST

Chugai Pharmaceutical Revenue

In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T JPY with 5.33% growth. Chugai Pharmaceutical had revenue of 300.60B in the quarter ending December 31, 2024, with 9.78% growth.

Revenue
1,170.61B JPY
Revenue Growth
+5.33%
P/S Ratio
n/a
Revenue / Employee
153.95M JPY
Employees
7,604
Market Cap
84.61B USD

Revenue Chart

* This company reports financials in JPY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,170.61B59.24B5.33%
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
SS Innovations International 16.04M
Veradigm 1.53B
Elite Pharmaceuticals 70.00M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
BioStem Technologies 210.49M
SANUWAVE Health 29.30M
Revenue Rankings

Chugai Pharmaceutical News

More News